Disease State
Resources

New 2020 clinical practice guidelines aim to provide evidence-based information about the diagnosis, evaluation, and treatment of postmenopausal osteoporosis for endocrinologists, physicians in general, regulatory bodies, health-related organizations, and interested laypersons.

This consensus document will present recommendations for the use of MHT for the relief of menopausal symptoms. It will consider the possible role of MHT in the prevention of chronic disorders associated with estrogen deficiency. Moreover, it will assess the benefit-versus-risk profile of MHT, including our current understanding of the effects of MHT on multiple organ systems.

The purpose of these guidelines is to present a framework for the evaluation, treatment, and follow-up of the patient—indeed, of the couple—who presents with sexual dysfunction. The conventional focus on male erectile dysfunction is incomplete because whenever a man experiences erectile difficulties, his wife or sexual partner suffers as well.

The purpose of this document is to provide guidelines for the diagnosis and treatment of hyperandrogenic disorders in women.

In these clinical practice guidelines, specific recommendations are made for determining the most effective methods of diagnosing and treating hypogonadism in adult male patients.

This algorithm for the comprehensive management of dyslipidemia and prevention of cardiovascular disease (CVD) complements the 2017 American Association of Clinical Endocrinologists/American College of Endocrinology (AACE/ACE) Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease and provides clinicians with a practical guide that considers the whole patient, their spectrum of risks and complications, and evidence-based approaches to treatment.

This clinical practice guideline is a practical tool that endocrinologists, other health care professionals, health-related organizations, and regulatory bodies can use to reduce the risks and consequences of dyslipidemia.

The newly released white paper, Computer Interpretable Guidelines in Thyroid Nodule Management, presented by Jeffrey R. Garber, MD, FACP, MACE, at our 2021 Annual Meeting is now available. This manuscript describes The Thyroid Nodule App (termed TNAPP), a novel interactive web-based tool that uses clinical, imaging, cytologic, and molecular marker data to guide clinical decision making to evaluate and manage thyroid nodules.

This document was prepared as a collaborative effort between the American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE) and Associazione Medici Endocrinologi (AME). These guidelines cover diagnostic and therapeutic aspects of thyroid nodular disease but not thyroid cancer management.

Hypothyroidism has multiple etiologies and manifestations. Appropriate treatment requires an accurate diagnosis and is influenced by coexisting medical conditions. This paper describes evidence-based clinical guidelines for the clinical management of hypothyroidism in ambulatory patients.

Thyrotoxicosis has multiple etiologies, manifestations, and potential therapies. Appropriate treatment requires an accurate diagnosis and is influenced by coexisting medical conditions and patient preference.

Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD)

Learn about our updated guideline for the care and management of people with or at risk for diabetes mellitus. The guideline features 170 updated and new evidence-based clinical practice recommendations for diabetes at every stage, including prevention, diagnosis, and treatment.

The 2021 AACE Advanced Diabetes Technology Guideline is a comprehensive, evidence based clinical practice guideline addressing the latest advancements in technology options for patients with diabetes. Key recommendations include key metrics for Continuous Glucose Monitoring (CGM), integration of technology with insulin pumps, and what health care professionals need to know in terms of safety.

This algorithm for the comprehensive management of persons with type 2 diabetes (T2D) was developed to provide clinicians with a practical guide that considers the whole patient, his or her spectrum of risks and complications, and evidence-based approaches to treatment.

This updated guideline provides evidence-based recommendations regarding the identification, screening, assessment, diagnosis, and treatment for a range of individuals with various causes of adult growth-hormone deficiency (GHD) and patients with childhood-onset GHD transitioning to adult care.

Acromegaly is a disorder characterized by growth hormone (GH) hypersecretion, multisystem-associated morbidities, and increased mortality. In 2004, the American Association of Clinical Endocrinologists (AACE) published medical guidelines for the clinical management of acromegaly (1 [“evidence level” or EL 4]).

The incidence of adrenal incidentaloma, a term coined in reference to the phenomenon of detecting an otherwise unsuspected adrenal mass on radiologic imaging, has been increasing and now approaches the 8.7% incidence reported in autopsy series.

This updated guideline provides evidence-based recommendations regarding the identification, screening, assessment, diagnosis, and treatment for a range of individuals with various causes of adult growth-hormone deficiency (GHD) and patients with childhood-onset GHD transitioning to adult care.

These AACE/ACE evidence-based clinical practice guidelines address key aspects of obesity care: screening, diagnosis, clinical evaluation, treatment options, therapy selection, and treatment goals.

Cosponsored by American Association of Clinical Endocrinology and The Obesity Society

Cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists

Osteoporosis is a growing major public health problem with impacts on quality of life across medical, social, and economic lines. These guidelines were developed to help clinicians reduce patients' risk of fractures and help maintain their quality of life.

Clinical practice guideline (CPG), clinical practice algorithm (CPA), and clinical checklist (CC, collectively CPGAC) development is a high priority of the American Association of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE).

The only previously published clinical practice guidelines on the management of patients with adrenal incidentalomas originated from a National Institutes of Health consensus conference and was published in 2002 (6 [EL 4]).